Outcome of challenge with coxsackievirus B4 in young mice after maternal infection with the same virus during gestation

FEMS Immunology and Medical Microbiology

Volumn 64, Issue 2, 2012, Pages 184-190

  Bopegamage, Shubhada ^a   Precechtelova, Jana ^a   Marosova, Lenka ^a   Stipalova, Darina ^a   Sojka, Martin ^a   Borsanyiova, Maria ^a   Gomolcak, Pavol ^b   Berakova, Katarina ^b   Galama, Jochem M D ^c  

^a SLOVAK MEDICAL UNIVERSITY   (Slovakia)

^b Cytopathos s r o   (Slovakia)

^c RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Challenge of offspring; Coxsackievirus B4; Gestation; Mice; Oral route of infection

Indexed keywords

GLUCOSE; VIRUS RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; BRAIN; CONTROLLED STUDY; COXSACKIE VIRUS B4; COXSACKIE VIRUS INFECTION; DISEASE SEVERITY; FEMALE; GESTATIONAL AGE; GLUCOSE BLOOD LEVEL; HEART; HISTOPATHOLOGY; INTRAUTERINE INFECTION; MALE; MOUSE; NEWBORN; NONHUMAN; OUTBRED STRAIN; PANCREAS; PANCREATITIS; PREGNANCY OUTCOME; PRIORITY JOURNAL; PROGENY; VIRUS STRAIN; WEANING;

ANIMALS; BLOOD GLUCOSE; BRAIN; COXSACKIEVIRUS INFECTIONS; ENTEROVIRUS B, HUMAN; FEMALE; HISTOCYTOCHEMISTRY; HYPERGLYCEMIA; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; MALE; MICE; MYOCARDIUM; PANCREAS; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; WEIGHT GAIN;

EID: 84856957723     PISSN: 09288244     EISSN: 1574695X     Source Type: Journal    
DOI: 10.1111/j.1574-695X.2011.00886.x     Document Type: Article

References (31)

1. Beck MA, Chapman NM, McManus BM, Mullican JC & Tracy S (1990) Secondary enterovirus infection in the murine model of myocarditis. Am J Pathol 156: 669-681.
2. Bopegamage S, Kovacova J, Vargova A et al. (2005) Coxsackie B virus infection of mice: inoculation by the oral route protects the pancreas from damage, but not from infection. J Gen Virol 86: 3271-3280.
3. Cheng L, Cheung P, Chan P, Wong H, Cheng F & Tang J (2006) Probable intrafamilial transmission of coxsackievirus B3 with vertical transmission, sever early-onset neonatal hepatitis, and prolonged viral RNA shedding. Pediatrics 118: 929-933.
4. Dahlquist GG, Frisk G, Ivarsson S, Svanberg L & Forsgren M (1995a) Indications that maternal Coxsackie B virus infection during pregnancy is a risk factor for childhood-onset IDDM. Diabetologia 38: 1371-1373.
5. Dahlquist G, Ivarsson S, Lindberg B & Forsgren M (1995b) Maternal enteroviral infection during pregnancy as a risk factor for childhood IDDM. A population-based case-control study. Diabetes 44: 408-413.
6. Dalldorf G & Gifford R (1954) Susceptibility of gravid mice to Coxsackievirus infection. J Exp Med 99: 21-27.
7. Elfving M, Svensson J, Oikarinen S, Jonsson B, Olofsson P, Sundkvist G, Lindberg B, Lernmark Å, Hyöty H & Ivarsson SA (2008) Maternal enterovirus infection during pregnancy as a risk factor in offspring diagnosed with type 1 diabetes between 15 and 30 years of age. Exp Diabetes Res 2008: 271958, Doi: 10.1155/2008/271958.
8. Galama J (1997) Enteroviral infections in the immunocompromised host. Rev Med Microbiol 3: 33-40.
9. Girn J, Kavoosi M & Chantler J (2002) Enhancement of Coxsackievirus B3 infection by antibody to a different Coxsackievirus strain. J Gen Virol 83: 351-358.
10. Hayward AM, Lemke LB, Bridgeford EC, Theve EJ, Jackson CN, Cunliffe-Beamer TL & Marini RP (2007) Biomethodology and surgical techniques. The Mouse in Biomedical Research Diseases, 2nd edn (Fox JG, Barthlod SW, Davisson MT, Newcomer CE, Quimby FW & Smit AL, eds), pp. 437-488. Academic press, Burlington, MA.
11. Horwitz MS, Ilie A, Fine C, Rodriguez E & Sarvetnick N (2003) Coxsackievirus-mediated hyperglycemia is enhanced by reinfection and this occurs independent of T cells. Virology 314: 510-520.
12. Hyöty H, Hiltunen M, Knip M et al. (1995) A prospective study of the role of Coxsackie B and other enterovirus infections in the pathogenesis of IDDM. Diabetes 44: 652-657.
13. Iwasaki T, Monma N, Satodate R, Kawana R & Kurata T (1985) An immunofluorescent study of generalized coxsackie virus B3 infection in a newborn infant. Acta Pathol Jpn 35: 741-748.
14. Jubayer RM, Roman DI, Mahavir S & Carmen F (2010) Influence of maternal gestational treatment with mycobacterial antigens on postnatal immunity in an experimental murine model. PLoS ONE 5: e9699.
15. Keyserling HL (1997) Other viral agents of perinatal importance. Varicella, parvovirus, respiratory syncytial virus and Enteroviruses. Clinics in Perinatology (Baniewicz C, eds), pp. 193-221. Saunders WB, Company, Philadelphia, PA.
16. Kishimoto C, Kurokawa M & Ochiai H (2002) Antibody-mediated immune enhancement in Coxsackievirus B3 myocarditis. J Mol Cell Cardiol 34: 1227-1238.
17. de Leeuw N, Melchers W, Willemse D, Balk A, de Jonge N & Galama J (1994) The value of PCR for the diagnosis of enteroviral infections. Serodiag Immun Inf D 6: 189-195.
18. Mata L, Urrutia JJ, Serrato G, Mohs E & Chin TDY (1977) Viral infections during pregnancy and in early life. Am J Clin Nutr 30: 1834-1842.
19. Michels TC & Tiu AY (2007) Second trimester pregnancy loss. Am Fam Physician 76: 1341-1346.
20. Modlin JF (1986) Perinatal echovirus infection: insights from a literature review of cases of serious illness and 16 outbreaks in nurseries. Rev Infect Dis 8: 918-926.
21. Modlin JF & Crumpacker CS (1982) Coxsackievirus B Infection in pregnant mice and transplacental infection of the fetus. Infect Immun 37: 222-226.
22. Moore M & Morens DM (1984) Enteroviruses including poliovirus. Textbook of Human Virology (Belshe R, eds), pp. 407-472. PSG Publishing company, Littleton, MA.
23. Morens DM, Burke DS & Halstead SB (2010) The Wages of Original Antigenic Sin. Emerging Infect Dis 16: 1023-1024.
24. Poeran J, Widschut H, Gavtant M, Galama J, Steegers E & van der Meijden W (2008) The incidence of neonatal herpes in the Netherlands. J Clin Virol 42: 321-325.
25. Sauter P & Hober D (2009) Mechanisms and results of the antibody-dependent enhancement of viral infections and role in the pathogenesis of coxsackievirus B-induced diseases. Microbes Infect 11: 443-451.
26. Soike K (1967) CVB3 infection of the pregnant mouse. J Infect Dis 117: 203-207.
27. Takada A & Kawaoka Y (2003) Antibody-dependent enhancement of viral infection: molecular mechanisms and in vivo implications. Rev Med Virol 13: 387-398.
28. Verboon-Maciolek MA, Krediet TG, van Loon AM, Kaan J, Galama JMD, Gerards LG & Fleer A (2002) Epidemiological survey of neonatal non-polio enterovirus infection in the Netherlands. J Med Virol 66: 241-245.
29. Viskari HR, Roivainen M, Reunanen A et al. (2002) Maternal first-trimester enterovirus infection and future risk of type 1 diabetes in the exposed fetus. Diabetes 51: 2568-2571.
30. William J, Watson WJ, Awadallah S & Jaqua MJ (1995) Intrauterine Infection With Coxsackievirus: is it a cause of congenital cardiac malformations? Infect Dis Obstet Gynecol 3: 79-81.
31. Yu JZ, Wilson JE, Wood SM, Kandolf RK, Klingel K, Yang D & McManus BM (1999) Secondary heterotypic versus homotypic infection by coxsackie B group viruses: impact on early and late histopathological lesions and virus genome prominence. Cardiovasc Pathol 8: 94-102.